These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
281 related items for PubMed ID: 10373064
1. Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS. Amigo ML, del Cañizo MC, Rios A, Garcia MA, Caballero MD, Martin A, Bermejo N, Vilches P, San Miguel JF. Bone Marrow Transplant; 1999 May; 23(10):997-1002. PubMed ID: 10373064 [Abstract] [Full Text] [Related]
2. Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome. Martínez-Climent JA, Comes AM, Vizcarra E, Benet I, Arbona C, Prósper F, Solano C, García Clavel B, Marugán I, Lluch A, García-Conde J. Bone Marrow Transplant; 2000 Jun; 25(11):1203-8. PubMed ID: 10849534 [Abstract] [Full Text] [Related]
3. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies. Laurenti L, Chiusolo P, Garzia MG, Zini G, Sorà F, Piccirillo N, Piccioni P, Zollino M, Leone G, Sica S. Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466 [Abstract] [Full Text] [Related]
4. Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation. Sevilla J, Rodríguez A, Hernández-Maraver D, de Bustos G, Aguado J, Ojeda E, Arrieta R, Hernández-Navarro F. Ann Hematol; 2002 Jan; 81(1):11-5. PubMed ID: 11807629 [Abstract] [Full Text] [Related]
5. Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma. Howe R, Micallef IN, Inwards DJ, Ansell SM, Dewald GW, Dispenzieri A, Gastineau DA, Gertz MA, Geyer SM, Hanson CA, Lacy MQ, Tefferi A, Litzow MR. Bone Marrow Transplant; 2003 Aug; 32(3):317-24. PubMed ID: 12858205 [Abstract] [Full Text] [Related]
6. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation. Sobecks RM, Le Beau MM, Anastasi J, Williams SF. Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956 [Abstract] [Full Text] [Related]
7. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D. Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [Abstract] [Full Text] [Related]
8. Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation. Del Cañizo Mf, Amigo Mf, Hernández JM, Sanz G, Núñez R, Carreras E, Alegre A, Cuesta B, Mataix R. Haematologica; 2000 Apr; 85(4):403-9. PubMed ID: 10756367 [Abstract] [Full Text] [Related]
9. Physician Education: Myelodysplastic Syndrome. Yoshida Y. Oncologist; 1996 Apr; 1(4):284-287. PubMed ID: 10388004 [Abstract] [Full Text] [Related]
10. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia. Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Andresen S, Kuczkowski E, Bolwell B. J Clin Oncol; 2006 Aug 01; 24(22):3604-10. PubMed ID: 16877727 [Abstract] [Full Text] [Related]
11. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A. Pathobiology; 2007 Aug 01; 74(2):97-114. PubMed ID: 17587881 [Abstract] [Full Text] [Related]
12. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders. Del Cañizo MC, Brufau A, Mota A, Lopez N, Fernandez ME, Vallejo C, Hernandez JM, Garcia JL, San Miguel JF. Haematologica; 1998 Jan 01; 83(1):3-7. PubMed ID: 9580461 [Abstract] [Full Text] [Related]
13. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group. Josting A, Wiedenmann S, Franklin J, May M, Sieber M, Wolf J, Engert A, Diehl V, German Hodgkin's Lymphoma Study Group. J Clin Oncol; 2003 Sep 15; 21(18):3440-6. PubMed ID: 12668650 [Abstract] [Full Text] [Related]
17. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome. Kröger N, Schetelig J, Zabelina T, Krüger W, Renges H, Stute N, Schrum J, Kabisch H, Siegert W, Zander AR. Bone Marrow Transplant; 2001 Oct 15; 28(7):643-7. PubMed ID: 11704786 [Abstract] [Full Text] [Related]
19. Factors that influence long-term hematopoietic function following autologous stem cell transplantation. Amigo ML, del Cañizo MC, Caballero MD, Vazquez L, Corral M, Vidriales B, Brufau A, San Miguel JF. Bone Marrow Transplant; 1999 Aug 15; 24(3):289-93. PubMed ID: 10455368 [Abstract] [Full Text] [Related]
20. [A study of hypoplastic myelodysplastic syndrome]. Sato Y, Mituhashi S, Otani K, Kamoshita M, Hasegawa Y, Ninomiya H, Nagasawa T, Abe T. Rinsho Ketsueki; 1993 Nov 15; 34(11):1431-7. PubMed ID: 8254904 [Abstract] [Full Text] [Related] Page: [Next] [New Search]